Correlation between MTA2 overexpression and tumour progression in esophageal squamous cell carcinoma

Experimental and Therapeutic Medicine

Volumn 3, Issue 4, 2012, Pages 745-749

  Liu, Y P ^a   Shan, B E ^a   Wang, X L ^a   Ma, L ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal cancer; Immunohistochemistry; Metastasis associated gene 2; Prognosis

Indexed keywords

MTA2 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 84863056662     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.475     Document Type: Article

References (15)

1. Shappell SB, Olson SJ, Hannah SE, et al: Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res 63: 2256-2267, 2003.
2. Toh Y, Kuninaka S, Endo K, et al: Molecular analysis of a candidate metastasis-associated gene, MTA1: possible interaction with histone deacetylase 1. J Exp Clin Cancer Res 19: 105-111, 2000.
3. Cui Y, Niu A, Pestell R, et al: Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 20: 2020-2035, 2006.
4. Nicolson GL, Nawa A, Toh Y, et al: Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 20: 19-24, 2003.
5. Saito M and Ishikawa F: The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J Biol Chem 277: 35434-35439, 2002.
6. Wong JJ, Hawkins NJ and Ward RL: Colorectal cancer: a model for epigenetic tumorigenesis. Gut 56: 140-148, 2007.
7. Yao YL and Yang WM: The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 278: 42560-42568, 2003.
8. Kumar R, Wang RA and Bagheri-Yarmand R: Emerging roles of MTA family members in human cancers. Semin Oncol 30: 30-37, 2003.
9. Liu YP, Ma L, Wang SJ, et al: Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma. EJSO 36: 155-159, 2010.
10. Zhang H, Stephens C and Kumar R: Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Clin Cancer Res 12: 1479-1486, 2006.
11. Fujita N, Kajita M, Taysavang P, et al: Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. Mol Endocrinol 18: 2937-2949, 2004.
12. Park SI, Zhang J, Phillips KA, et al: Targeting SRC family kinases inhibits growth and lymph node metastases of prostate cancer in an orthotopic nude mouse model. Cancer Res 68: 3323-3333, 2008.
13. Manavathi B, Singh K and Kumar R: MTA family of coregulators in nuclear receptor biology and pathology. Nucl Recept Signal 5: e010, 2007.
14. Li W, Zhang J, Liu X, Xu R and Zhang Y: Correlation of appearance of metastasis-associated protein1 (Mta1) with spermatogenesis in developing mouse testis. Cell Tissue Res 329: 351-362, 2007.
15. Adjei AA: Pemetrexed in the treatment of selected solid tumors. Semin Oncol 29: 50-53, 2002.